July 29, 2019 | Letisia Marquez
City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.
Researcher receives $1.35M Department of Defense grant for breast metastasis study
August 20, 2019 | Michael Easterling
Rahul Jandial, M.D., Ph.D., has received the “Breakthrough” award from the Department of Defense's Breast Cancer Research Program to support his study of leptomeningeal disease, which is characterized by the spreading of tumor cells to the lining of the brain and spinal cord.
Innovative approach using KITE-439 in targeting HPV-related malignancies
August 20, 2019 | City of Hope
HPV16-induced cancers, a strain that causes about 70% of all cervical cancers worldwide, are ideal candidates for targeted T cell therapy due to their nonself antigens.
Cancer screening guidance from City of Hope experts
August 16, 2019 | Samantha Bonar
August 16 is National Cancer Screening Day for breast, cervical and colorectal cancer. The day is an effort to increase awareness and education for breast, cervical and colorectal cancers.
City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer
August 15, 2019 | Letisia Marquez
Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.
Researcher Awarded $3M Grant to Study Genomics of Breast Cancer in Latinas
August 14, 2019 | Jenny Peters
City of Hope researcher Susan Neuhausen, Ph.D., is studying genomic breast cancer risk among Latinas. The research is vital, as Latinas are underrepresented in studies of breast cancer and genetic risk assessment.
New ‘liquid biopsy’ blood test could improve breast cancer diagnostics
August 7, 2019 | Letisia Marquez
Developed by TGen and partners, the test could help avoid unnecessary surgeries and enable physicians to continuously monitor cancer. It works by measuring tiny particles of tumor DNA circulating in a patient's bloodstream.
From Oranges, a Powerful Potential Cancer Fighter
June 13, 2019 | Wayne Lewis
Sharad Singhal, Ph.D., research professor in the Department of Medical Oncology and Therapeutics Research, leads investigations focusing on a small molecule that is abundant in the pith of citrus fruit.